BioMarin Pharmaceutical Inc. (BMRN) Shares Sold by Aperio Group LLC

Lloyd Doyle
November 9, 2017

The Artal Group Sa holds 250,000 shares with $22.71M value, up from 50,000 last quarter.

Currently, BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical (NASDAQ:BMRN) last announced its quarterly earnings results on Thursday, October 26th. It has underperformed by 11.41% the S&P500. The Return on Investment (ROI) ratio of BioMarin Pharmaceutical Inc.

According to Finviz reported data, The SMA20 of the stock is at -4.28 percent, SMA50 is -6.9 percent, while SMA200 is -6.49 percent.

Price targets show what analysts believes a stock will be worth at the end of a certain time period. Janney Montgomery Scott holds 0.01% or 11,565 shares.

BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) has a current ERP5 Rank of 13505. About 6.05 million shares traded or 128.30% up from the average.

Here we will take a look at the Gross Margin Score of BioMarin Pharmaceutical Inc. It has underperformed by 11.41% the S&P500. More interesting news about Zoetis Inc (NYSE:ZTS) was released by: and their article: "Zoetis (ZTS) Q3 Earnings & Sales Beat Estimate; 2017 View Up" with publication date: November 02, 2017. Similarly, the Earnings Yield Five Year Average is the five year average operating income or EBIT divided by the current enterprise value. DE's profit will be $453.00 million for 23.88 P/E if the $1.41 EPS becomes a reality.

Stock analysts at Jefferies Group issued their Q3 2018 earnings per share (EPS) estimates for shares of BioMarin Pharmaceutical in a research note issued to investors on Thursday, Zacks Investment Research reports.

Investors sentiment increased to 1 in Q2 2017. Its up 0.06, from 1.2 in 2017Q1. Institutional investors and hedge funds own 97.54% of the company's stock. 71 funds opened positions while 178 raised stakes. 209.56 million shares or 1.26% less from 212.23 million shares in 2017Q1 were reported. The company's market cap is $14.73 billion. (NASDAQ:BMRN). Apg Asset Management Nv reported 0.01% stake. Blackrock reported 0.08% in Dollar General Corp. The New York-based Baker Bros. Lateef Investment LP owns 532,334 shares or 3.46% of their U.S. portfolio. ATR remains at 2.17 while Beta component of the stock stands at 1.81. Zwj Inv Counsel holds 253,954 shares. Investors may use Price to Book to display how the market portrays the value of a stock. Andra Ap reported 0.04% stake. The rating was maintained by Cowen & Co on Thursday, August 24 with "Buy". Therefore 17% are positive. In this case performance of tends to percentage rate of return for a stock for a given time frame. Wellington Mngmt Grp Llp accumulated 171,385 shares. The company was maintained on Tuesday, October 3 by Robert W. Baird. The firm has "Buy" rating by Stifel Nicolaus given on Friday, October 27. Morgan Stanley initiated it with "Overweight" rating and $110 target in Tuesday, February 7 report. The rating was maintained by BMO Capital Markets on Thursday, July 6 with "Buy". The firm has "Buy" rating by Piper Jaffray given on Friday, September 29.

Investors sentiment increased to 1.26 in 2017 Q2. Its up 0.06, from 1.2 in 2017Q1. The company exchanged hands with 3019764 shares compared to its average daily volume of 1.08M shares. 168.09 million shares or 1.78% more from 165.15 million shares in 2017Q1 were reported. Blue Jay Cap Mgmt Ltd Llc reported 94,454 shares. Eventide Asset Ltd Company holds 75,000 shares. Ameriprise owns 934,537 shares or 0.04% of their USA portfolio. Elk Creek Ltd Liability accumulated 3,081 shares. The price index of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) for 514 shares. Citigroup initiated BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) for 21,507 shares.

Dell Technologies Inc. a United States of America based Company, belongs to Technology sector and Diversified Computer Systems industry.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 1.9 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. Citadel Ltd Liability stated it has 242,021 shares. 170,905 were accumulated by Thrivent For Lutherans. Tci Wealth Advisors Inc owns 60 shares for 0% of their portfolio. 92,521 were reported by Citigroup. Insiders sold 40,686 shares of company stock worth $3,736,318 over the last ninety days. Healthcor Management Lp sold 607,666 shares as the company's stock rose 14.85% with the market. Also, EVP Jeffrey Robert Ajer sold 3,521 shares of BioMarin Pharmaceutical stock in a transaction dated Friday, September 22nd. BioMarin Pharmaceutical Inc. has a 52 week low of $79.50 and a 52 week high of $100.51. The shares were sold at an average price of $90.50, for a total transaction of $1,357,500.00. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has risen 5.29% since November 8, 2016 and is uptrending. Therefore 70% are positive. On Thursday, October 19 the stock rating was maintained by SunTrust with "Buy". BioMarin Pharmaceutical presently has a consensus rating of "Hold" and a consensus target price of $111.55. The rating was maintained by Oppenheimer with "Perform" on Wednesday, November 25. (NASDAQ:BMRN) was sold by Davis George Eric on Monday, June 5. The stock has "Overweight" rating by Barclays Capital on Friday, August 5. Comgest Global Investors S.A.S. increased its position in shares of BioMarin Pharmaceutical by 6.3% during the third quarter. Leerink Swann has "Outperform" rating and $120 target. The firm has "Conviction Buy" rating by Goldman Sachs given on Monday, March 7.

Among 27 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 19 have Buy rating, 0 Sell and 8 Hold. The company was maintained on Wednesday, August 5 by William Blair.

Other reports by Iphone Fresh

Discuss This Article